ASMB - Pendapatan operasional sadurunge ngurangi amortisasi Assembly Bio

Logo grafis assemblybio.com (ASMB)

Assembly Biosciences is battling powerful corporations within the high-risk hepatitis therapy sector. On GURU.Markets, the actual size of operating profit reflects the asset's dynamics, where the value of 0.00 serves as the current indicator. The firm's resilience is based on an R&D partnership with Gilead to develop new inhibitors; however, the lack of sales during the testing phase is converting investments into rising costs.

ASMB (Assembly Biosciences, Inc.) riwayat Bathi operasional EBITDA saka 23.11.2025 nganti 10.11.2026

Assembly Biosciences, Inc. (ASMB) - rincian metrik lan laporan keuangan

- rega saham lan target rega konsensus:
Bagan rega Assembly Corp|ASMB - Prakiraan konsensus analis
- statistik kapitalisasi pasar:
Kapitalisasi pasar Assembly Biosciences|ASMB - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data ekuitas miturut neraca:
Aset Bersih saben Siji Saham Assembly Biosciences|ASMB - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku assemblybio.com|ASMB - Aset Agregat Perusahaan
- indikator total utang lan likuiditas perusahaan:
Rasio Kabeh Utang marang Dana Pribadi Assembly Biosciences|ASMB - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Assembly Bio|ASMB - Utang perusahaan|Utang-utang marang aset resik Assembly Biosciences|ASMB - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Assembly Biosciences|Likuiditas darurat assemblybio.com
- indikator pendapatan resik lan kelipatan nilai:
ASMB - Bathi resik perusahaan|Bathi mangsa ngarep Assembly Biosciences|ASMB - Pangali P/E|Rega marang bathi mangsa ngarep assemblybio.com|ASMB - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Assembly Biosciences|ASMB - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Assembly Biosciences|ASMB - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan assemblybio.com|ASMB - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Assembly Biosciences
Analisis kabeh metrik perusahaan:ASMB Assembly Corp
Produk merek Assembly Biosciences, Inc.

Amidst fierce competition with pharmaceutical behemoths to develop a hepatitis B cure, the financial stability of Assembly Biosciences (ASMB) depends on the efficiency of its cost management. By analyzing the current EBITDA, investors assess the business's ability to generate cash flow before taxes and interest, which determines the company's liquidity and its risk appetite in the scientific race.

Pesaing Assembly Biosciences (ASMB)

Arrowhead Corp - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Mirum Pharmaceuticals - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Dynavax Technologies Corp DVAX|ABUS (Arbutus Biopharma Corporation) - Bathi operasional sadurunge ngurangi amortisasi|IVA (Inventiva SA) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|GYRE (Gyre Corp) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Galectin GALT|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Genfit S.A. (GNFT)|DRRX (durect.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA ALGS (Aligos Therapeutics, Inc.)|Bathi operasional EBITDA BioVie Inc BIVI|GLMD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi ENDRA Corp NDRA|hepionpharma.com (HEPA) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi